NCT06069583 Implementation of Support in the Care of Adults Living With Type 1 Diabetes
| NCT ID | NCT06069583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University |
| Condition | Type 1 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 322 participants |
| Start Date | 2024-05-05 |
| Primary Completion | 2027-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 322 participants in total. It began in 2024-05-05 with a primary completion date of 2027-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the "Support" platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration "Support" in clinical care.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults) * Have access to Internet * Use of an active email address * Comprehension of English or French * Live in Canada Exclusion Criteria: \- Unable to use the Support platform
Contact & Investigator
Anne-Sophie Brazeau, PhD
PRINCIPAL INVESTIGATOR
School of human nutrition - McGill University
Frequently Asked Questions
Who can join the NCT06069583 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06069583 currently recruiting?
Yes, NCT06069583 is actively recruiting participants. Contact the research team at anne-sophie.brazeau@mcgill.ca for enrollment information.
Where is the NCT06069583 trial being conducted?
This trial is being conducted at Montreal, Canada, Montreal, Canada, Québec, Canada, Terrebonne, Canada.
Who is sponsoring the NCT06069583 clinical trial?
NCT06069583 is sponsored by McGill University. The principal investigator is Anne-Sophie Brazeau, PhD at School of human nutrition - McGill University. The trial plans to enroll 322 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.